pillbase.ru

COSYNTROPIN

Active substance: cosyntropin

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · COSYNTROPIN .25 mg/mL

United StatesActive

Marketing holder: HF Acquisition Co LLC, DBA HealthFirst

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Синактен Депо
    суспензия для внутримышечного введения, 1 мг/мл, 1 мл (original in Russian, GRLS)
    П N013438/01
    Квесткор Оперейшнс Лимитед
  • Синактен депо®
    суспензия для внутримышечного введения, 1 мг/мл, 1 мл (original in Russian, GRLS)
    П N013438/01
    Новартис Фарма АГ
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c4-d465-7522-a26d-9ef68e02989d,01a120c4-d469-7300-95c7-8e21e4ecc3bc;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-bb59-71ec-922d-9f001446c25f,01a12092-b863-7703-ad3c-58d2e3e6c8ce,01a12095-114e-70e3-9fc7-e499a4603351,01a12096-1efc-76ff-b9c3-8bff60b2b107,01a12097-a1d9-7894-b889-aea9bf2e8c14;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
51662-1567
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 51662-1567 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 51662-1567 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 51662-1567 · Verified 2026-10-09 · open in source